Search

everythinglearnresearchcommunity

for

Search:↓

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

Stress can worsen skin and hair conditions by affecting the skin's immune response and hormone levels.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

PCOS is caused by both genetics and environmental factors like diet and obesity.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Male and female skin differ in many ways, which could lead to gender-specific skin treatments.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

High androgen levels in young women with PCOS are linked to higher blood pressure.

Estrogen therapy can reduce skin aging but has cancer risks.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Modern lifestyles, including poor diet, stress, and long-term use of certain medications, hinder the body's ability to heal from inflammation, leading to chronic diseases.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

Oral spironolactone's effectiveness for adult female acne is not well-supported by strong evidence.

Stress increases nerve fibers and immune cell activity in mouse skin, possibly worsening skin conditions.

Eflornithine cream effectively reduces women's unwanted facial hair but hair returns if treatment stops.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

Lowering testosterone speeds up wound healing in male mice.

Researchers found that hair shedding happens mostly when new hair is growing and involves a unique process.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.